Oral Abstract Session:
174. Respiratory Infections in Children
Saturday, October 22, 2011: 1:45 PM-3:15 PM
Room: 156ABC

Learning Objectives:

none

Target Audience: none, Academicians

Topical Category: P. Pediatric and perinatal infections

Tracks: Pediatric ID

Moderators:  Ron Dagan, MD, Ben-Gurion Univ. and Soroka Univ. Med. Ctr. and Krow Ampofo, MD, University of Utah

Presentations:

2:00 PM
Randomized, Double-Blind, Pilot Study of Nitazoxanide (NTZ) Versus Placebo (PCB) for the Treatment of Symptoms Associated with Viral Respiratory Infection (VRI) in Children
Nicolas Lopez-Chegne, MD ; Luis-Martin Julcamoro, MD ; Jean-Francois Rossignol, MD, FRCPath, PhD, FRSC ; Maria Carrion, MD ; Matthew Bardin, PharmD, BCPS

2:15 PM
Impact of PCV13 on Pneumococcal Colonization in Massachusetts Children
Grace M. Lee, MD, MPH ; Stephen I. Pelton, MD MPH ; Susan Huang, MD, MPH ; M. Maya Dutta-Linn, MPH ; Matthew Lakoma, MPH ; William P. Hanage, PhD ; Ken Kleinman, ScD ; Jonathan A. Finkelstein, MD, MPH

2:45 PM
Impact of Influenza A 2009 H1N1 (IA) on S. Aureus Nasal Colonization in Children
Howard Faden, MD ; Kiran Majeed, MD ; Alan Lesse, MD

3:00 PM
Invasive Disease caused by Haemophilus influenzae serotype a, an emerging pathogen in Alaska
Michael Bruce, MD, MPH ; Tammy Zulz, MPH ; Carolynn DeByle, BS ; Rosalyn Singleton, MD ; Debby Hurlburt, RN BSN ; Dana Bruden, MS ; Karen Rudolph, PhD ; Thomas Hennessy, MD MPH ; Joseph Klejka, MD ; Jay Wenger, MD

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

R. Dagan, Berna/Crucell: Grant Investigator, Investigator, Scientific Advisor and Speaker's Bureau, Consulting fee, Research grant and Speaker honorarium
GlaxoSmithKline: Scientific Advisor and Speaker's Bureau, Consulting fee and Speaker honorarium
MSD: Grant Investigator, Investigator and Scientific Advisor, Consulting fee and Research grant
Novartis: Scientific Advisor, Consulting fee
Protea: Grant Investigator, Investigator and Shareholder, Research grant
Pfizer (Wyeth): Grant Investigator, Investigator, Scientific Advisor and Speaker's Bureau, Consulting fee, Research grant and Speaker honorarium

K. Ampofo, None

K. Ampofo, None

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.